Detalles de la búsqueda
1.
PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial.
Nat Cancer
; 4(4): 535-549, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37038006
2.
Differential Survival and Therapy Benefit of Patients with Breast Cancer Are Characterized by Distinct Epithelial and Immune Cell Microenvironments.
Clin Cancer Res
; 28(5): 960-971, 2022 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34965952
3.
IHC-based Ki67 as response biomarker to tamoxifen in breast cancer window trials enrolling premenopausal women.
NPJ Breast Cancer
; 7(1): 138, 2021 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34671036
4.
Carboplatin-Cyclophosphamide or Paclitaxel without or with Bevacizumab as First-Line Treatment for Metastatic Triple-Negative Breast Cancer (BOOG 2013-01).
Breast Care (Basel)
; 16(6): 598-606, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35087363
5.
POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer Patients.
Clin Cancer Res
; 25(22): 6598-6605, 2019 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31439579
6.
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial.
Nat Med
; 25(6): 920-928, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31086347
7.
Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial.
Nat Med
; 25(7): 1175, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31209337
8.
Independent replication of polymorphisms predicting toxicity in breast cancer patients randomized between dose-dense and docetaxel-containing adjuvant chemotherapy.
Oncotarget
; 8(69): 113531-113542, 2017 Dec 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-29371927
9.
Trastuzumab in combination with weekly paclitaxel and carboplatin as neo-adjuvant treatment for HER2-positive breast cancer: The TRAIN-study.
Eur J Cancer
; 74: 47-54, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28335887
Resultados
1 -
9
de 9
1
Próxima >
>>